Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Healthcare Report.
Press releases published on July 8, 2025
Greenspace Leads Scientific Revival of Ayurveda With New Quantum-Based Approach
GlobeNewswire
·
July 8, 2025
BANGALORE, India, July 08, 2025 (GLOBE NEWSWIRE) -- Greenspace Herbs, a leader in advanced Ayurvedic innovation, is leading a scientific revival of Ayurveda through its expanding work in Quantum Ayurveda™, a forward-thinking approach to herbal medicine …
BiomX Announces Publication in Nature Communications of Phage Cocktail BX004 Phase 1b/2a Part 1 Data Demonstrating Strong Activity in Cystic Fibrosis
GlobeNewswire
·
July 8, 2025
Premier research journal article provides validation for BiomX’s phage therapy platform, showcasing first-in-human Phase 1b/2a trial results for antibiotic-resistant P. aeruginosa infections New, updated data demonstrates a further bacteria reduction of 2. …
Highridge to Introduce activL® Lumbar Disc
GlobeNewswire
·
July 8, 2025
WESTMINSTER, Colo., July 08, 2025 (GLOBE NEWSWIRE) -- Highridge Medical, one of the world’s largest privately held Spine companies with a strong portfolio supported by extensive clinical evidence, announced today that it has licensed the U.S. rights of …
Clover Health to Report Second Quarter 2025 Financial Results on August 5, 2025
GlobeNewswire
·
July 8, 2025
WILMINGTON, Del., July 08, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its financial results after the market closes on Tuesday, August 5, 2025. …
Calidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision Genetic Medicine Platform for Cancer Treatment
GlobeNewswire
·
July 8, 2025
NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Calidi Biotherapeutics Inc. (NYSE American: CLDI) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN ( …
QHS Healthcare, Powered by QHSLab, Inc. (OTCQB: USAQ), Opens Doors in Miami to Expand Access to Mental Health Services
GlobeNewswire
·
July 8, 2025
Innovative initiative combines QHSLab’s digital platform with on-site behavioral health services to advance timely, effective care. MIAMI, FL, July 08, 2025 (GLOBE NEWSWIRE) -- QHSLab Inc. (the “Company”) (OTCQB: USAQ), a digital health company advancing …
Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy
GlobeNewswire
·
July 8, 2025
Independent advisor appointed to assess feasibility and strategic benefit of a partial cryptocurrency-based treasury reserve Initiative aims to diversify capital positioning while retaining focus on IP-driven pharmaceutical development NAPLES, Fla. and …
Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting
GlobeNewswire
·
July 8, 2025
HINGHAM, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, announced its participation in the inaugural Endovascular Robotics session at the Society of Robotic …
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment
GlobeNewswire
·
July 8, 2025
SEATTLE, July 08, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 Labs, Inc. (OTC: FITY), a Nevada-based pioneer in AI-driven drug repurposing and AI-driven functional medicine, today unveiled a transformative Game Plan to achieve a $50 million valuation and …
SlimJaro Botanical Approaches Gain Interest in 2025 for Inflammation-Related Metabolic Wellness
GlobeNewswire
·
July 8, 2025
New York City, NY, July 08, 2025 (GLOBE NEWSWIRE) -- SlimJaro Introduced as a Gentle Formulation Aimed at Inflammation Linked Weight Challenges: In 2025, health conversations surrounding weight loss have increasingly focused on the role of chronic …
SRX Health Completes $7.3 Million Financing Led by Insiders and Existing Investors and Announces Financial Commitment of Up to $50 Million
GlobeNewswire
·
July 8, 2025
TAMPA, Fla., July 08, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (“SRX Health” or the “Company”), a leading global health and wellness company, today announced the successful closing of a $7.3 million convertible note …
Progyny, Inc. Provides Business Update and Announces Details for Its Second Quarter 2025 Results Report
GlobeNewswire
·
July 8, 2025
Operational and Financial Flexibility Enhanced Through New Credit Facility Second Quarter Results Anticipated to be Slightly Above Previously Provided Financial Guidance NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or …
SeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI)
GlobeNewswire
·
July 8, 2025
DENVER, July 08, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life announced …
Alignment Healthcare Wins Key Legal Victory: Arizona Medicare Advantage Plans Elevated to 4 Stars
GlobeNewswire
·
July 8, 2025
ORANGE, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) announced today that a federal court ruled in its favor on June 9 in a legal challenge against the Centers for Medicare …
Esperion Reaches Settlement Agreement with Third ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) Prior to April 19, 2040
GlobeNewswire
·
July 8, 2025
ANN ARBOR, Mich., July 08, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that it has entered into a settlement agreement with Accord Healthcare Inc. This agreement resolves the patent litigation brought by Esperion against Accord …
OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress
GlobeNewswire
·
July 8, 2025
MIAMI and JERUSALEM, July 08, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (“OPKO”) and Entera Bio Ltd. (NASDAQ: ENTX) (“Entera”) today announced that their abstract “First-in-Class Oral GLP-2 Analog for Treatment of Short Bowel Syndrome” has …
Humacyte announces Symvess™ ECAT Approval from U.S. Defense Logistics Agency
GlobeNewswire
·
July 8, 2025
DURHAM, N.C., July 08, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, announced today that Symvess has been …
Certara Announces Expansion of Clinical Technology Collaboration with Merck
GlobeNewswire
·
July 8, 2025
RADNOR, Pa., July 08, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced a new collaboration with Merck, known as MSD outside of the United States and Canada, that expands Merck’s use …
Quantum BioPharma Submits its Candidate Breakthrough Patented Drug for Multiple Sclerosis for Fast-Track Program in the United Kingdom
GlobeNewswire
·
July 8, 2025
TORONTO, July 08, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today …
Vaxart Announces Trading on OTCQX Best Market
GlobeNewswire
·
July 8, 2025
SOUTH SAN FRANCISCO, Calif., July 08, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, …